The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 study of NOX66 in combination with carboplatin in patients with end stage solid tumours.
 
Paul L. de Souza
Honoraria - Janssen
Consulting or Advisory Role - Astellas Pharma; GlaxoSmithKline; Janssen; Pfizer
Research Funding - Multiple pharma companies
Expert Testimony - Janssen
 
Marinella Messina
Employment - Noxopharm
Stock and Other Ownership Interests - Noxopharm
 
Ian Minns
Employment - Noxopharm; Regeneron
Stock and Other Ownership Interests - Bristol-Myers Squibb; Noxopharm
 
Mikheil Shavdia
Stock and Other Ownership Interests - JSC Neo Medi
Travel, Accommodations, Expenses - Berlin-Chemie; Pfizer; Zor
 
Nana Chikhladze
No Relationships to Disclose
 
Graham Kelly
Employment - Noxopharm; Noxopharm (I)
Stock and Other Ownership Interests - Noxopharm; Noxopharm (I)
Patents, Royalties, Other Intellectual Property - Noxopharm Limited